What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2025-04-14 compared with 2024-04-16 · 44 added, 24 removed, 26 unchanged (72% of the section changed)

2 unchanged sentences

“ATMV,” and “ATMVR” respectively.

Our units commenced public trading on December 23, 2022, and our ordinary

shares and rights commenced separate trading on January 25, 2023.

of date of this Form 10-K, we had three holders of record of our ordinary shares, one holders of record of our units and three holders

of record of our rights.

Our units commenced public trading on December 23, 2022, and our Ordinary Shares

and Rights commenced separate trading on January 25, 2023.

of April 14, 2025, we had one holder of record of our Ordinary Shares, one holders of record of our Units, and one holder of record

of our Rights.

have not paid any cash dividends on our Ordinary Shares to date and do not intend to pay cash dividends.

6 unchanged sentences

Sale of Equity Securities

February 7, 2022, our sponsor acquired 1,725,000 founder shares for an aggregate purchase price of $25,000.

We also issued an aggregate

of 125,000 EBC founder shares to EBC on July 11, 2022 for an aggregate purchase price of $1,750.

September 28, 2021, our Sponsor acquired 1,437,500 Founder Shares for an aggregate purchase price of $25,000.

On January 8, 2022, our

Sponsor acquired an additional 287,500 Founder Shares for no additional consideration, resulting in our Sponsor holding an aggregate

of 1,725,000 Founder Shares.

Concurrent with the closing of the Initial Public Offering, our Sponsor sold to Chardan or its designees

132,825 of these Founder Shares at a purchase price of $2.00 per share and an aggregate purchase price of $265,650.

Simultaneously

with the closing of the IPO, pursuant to the Private Placement Unit Purchase Agreement, the Company completed the private sale of 365,000

units (the “Private Placement Units”) to the Sponsor and 25,000 Private Placement Units to EBC at a purchase price of $10.00

per Private Placement Unit, generating gross proceeds to the Company of $3,900,000.

The Private Placement Units are identical to the

Units sold in the IPO.

Private Placement Units to the Sponsor and 25,000 Private Placement Units to EBC at a purchase price of $10.00 per Private Placement

Unit, generating gross proceeds to the Company of $3,900,000.

The Private Placement Units are identical to the Units sold in the IPO.

No underwriting discounts or commissions were paid with respect to such sale.

The issuance of the Private Placement

Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

underwriting discounts or commissions were paid with respect to such sale.

The issuance of the Private Placement Units was made pursuant

to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

On December 29, 2022, simultaneously

with the sale of the over-allotment Units, the Company consummated the private sale of an additional 37,904 Private Placement Units to

the Sponsor and 2,596 Private Placements to EBC, generating additional gross proceeds of $405,000.

No underwriting discounts

or commissions were paid with respect to such sale.

The issuance of the Private Placement Units was made pursuant to the exemption from

registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

On December 29, 2022, simultaneously with the sale

of the over-allotment Units, the Company consummated the private sale of an additional 37,904 Private Placement Units to the Sponsor

and 2,596 Private Placements to EBC, generating additional gross proceeds of $405,000.

April 18, 2023, the Sponsor transferred an aggregate of 1,035,000 Founder Shares to Peace Capital Limited.

December 22, 2022, the Company consummated the initial public offering of 6,000,000 Units (the “Units” and, with respect

8 unchanged sentences

underwriter was paid a cash underwriting discount of $0.20 per Unit, or $1,725,000 in the aggregate upon the closing of the Initial Public

June 3, 2022, we issued an unsecured promissory note to our Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate of $150,000 to cover expenses related to the IPO.

Promissory Note expired on the consummation of the IPO.

costs related to the issuances described above amounted to $ 3,734,629 consisting of $ 1,725,000

of underwriting fees, and $2,009,629 of other offering costs.

After deducting the underwriting discounts and commissions and offering

expenses, the total net proceeds from the initial public offering and the sale of the Private Placement Units $71,030,000 (or $10.20

per share sold in the initial public offering) was placed in the Trust Account.

June 3, 2022, we issued an unsecured promissory note to our Sponsor (the “Promissory Note”), pursuant to which we could

borrow up to an aggregate of $150,000 to cover expenses related to the initial public offering.

On April 11, 2024, we amended and restated the Promissory Note with AlphaVest Holding LP to extend the maturity date

to the earlier of:

(i) September 12, 2024 or (ii) promptly after the date of the consummation of the business combination.

The Promissory

Note expired on September 12, 2024.

costs related to the issuances described above amounted to $3,734,629 consisting of $1,725,000 of underwriting fees, and $2,009,629 of other offering costs.

After deducting the underwriting discounts and commissions and offering expenses, the

total net proceeds from the initial public offering and the sale of the Private Placement Units $71,030,000 (or $10.20 per share sold

in the initial public offering) was placed in the Trust Account.

December 21, 2023, a special meeting of the stockholders was held to extend the date by which the Company must consummate a business

In connection with this meeting, the stockholders of record were provided the opportunity to exercise their redemption rights.

Holders of 2,174,171 Ordinary Shares properly exercised their rights to redeem their shares for cash at a redemption price of approximately

$10.71 per share, for an aggregate redemption amount of approximately $ 23,282,935.83.

Following the redemptions, the Company has 7,006,329

Ordinary Shares outstanding.

December 18, 2024, a special meeting of the stockholders was held to extend the date by which the Company must consummate a business

In connection with this meeting, the stockholders of record were provided the opportunity to exercise their redemption rights.

Holders of 3,151,473 Ordinary Shares properly exercised their rights to redeem their shares for cash at a redemption price of approximately

$11.41 per share, for an aggregate redemption amount of approximately $35,956,676.

Following the redemptions, the Company has 3,854,856

Ordinary Shares outstanding.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity